In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia
Research output: Contribution to journal › Journal article › Research › peer-review
Leukemic cells from 230 children with newly diagnosed B-cell precursor ALL were tested for in vitro drug resistance to a panel of anti-cancer drugs. Minimal residual disease (MRD) was measured by RQ-PCR. During follow-up, 24 relapses occurred in the 159 children with MRD
| Original language | English |
|---|---|
| Journal | Leukemia Research |
| Volume | 35 |
| Issue number | 4 |
| Pages (from-to) | 472-8 |
| Number of pages | 7 |
| ISSN | 0145-2126 |
| DOIs | |
| Publication status | Published - 2011 |
ID: 40193239